Allstate (NYSE:ALL) Stock Gets Price Target Boost from Mizuho

Allstate (NYSE:ALL – Get Free Report) had its price objective lifted by investment analysts at Mizuho from $295.00 to $311.00 in a research report issued on Friday, Benzinga reports. The firm currently has an “outperform” rating on the insurance provider’s stock. Mizuho‘s target price would suggest a potential upside of 16.49% from the stock’s previous close.

Other research analysts have also issued research reports about the stock. Wall Street Zen lowered shares of Allstate from a “buy” rating to a “hold” rating in a research report on Saturday, November 7th. Citigroup lifted their price objective on Allstate from $215.00 to $225.00 and gave the company a “sell” rating in a report on Friday, November 6th. Jefferies Financial Group decreased their price objective on Allstate from $310.00 to $292.00 and set a “buy” rating on the stock in a report on Tuesday, October 6th. TD Cowen upped their price objective on Allstate from $231.00 to $260.00 and gave the company a “hold” rating in a research note on Wednesday, September 23rd. Finally, Barclays increased their target price on Allstate from $221.00 to $228.00 and gave the stock an “underweight” rating in a report on Thursday, November 5th. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $274.90.

View Our Latest Analysis on ALL

Allstate Trading Up 0.1%

Shares of Allstate stock opened at $266.99 on Friday. Allstate has a 52-week low of $191.13 and a 52-week high of $281.11. The firm has a market capitalization of $66.07 billion, a PE ratio of 6.05, a price-to-earnings-growth ratio of 1.16 and a beta of 0.13. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.37 and a quick ratio of 0.37. The company’s fifty day moving average price is $247.52 and its two-hundred day moving average price is $233.24.

Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The insurance provider reported $9.76 EPS for the quarter, topping analysts’ consensus estimates of $6.89 by $2.87. Allstate had a net margin of 16.57% and a return on equity of 38.37%. The company had revenue of $17.35 billion during the quarter, compared to the consensus estimate of $15.87 billion. During the same period last year, the firm earned $11.17 EPS. The firm’s revenue for the quarter was up .5% compared to the same quarter last year. On average, analysts expect that Allstate will post 38.47 EPS for the current year.

Hedge Funds Weigh In On Allstate

Institutional investors have recently added to or reduced their stakes in the company. Stonebrook Private Inc. grew its position in Allstate by 9.2% during the 3rd quarter. Stonebrook Private Inc. now owns 1,726 shares of the insurance provider’s stock worth $383,000 after acquiring an additional 145 shares during the last quarter. American Century Companies Inc. increased its holdings in Allstate by 7.5% during the 3rd quarter. American Century Companies Inc. now owns 1,938,127 shares of the insurance provider’s stock valued at $429,994,000 after purchasing an additional 134,737 shares in the last quarter. Prostatis Group LLC raised its position in Allstate by 4.4% in the 3rd quarter. Prostatis Group LLC now owns 2,860 shares of the insurance provider’s stock valued at $634,000 after purchasing an additional 121 shares during the last quarter. Defiance ETFs LLC raised its position in Allstate by 13.6% in the 3rd quarter. Defiance ETFs LLC now owns 1,155 shares of the insurance provider’s stock valued at $256,000 after purchasing an additional 138 shares during the last quarter. Finally, Kestra Advisory Services LLC raised its position in Allstate by 11.2% in the 3rd quarter. Kestra Advisory Services LLC now owns 37,302 shares of the insurance provider’s stock valued at $8,276,000 after purchasing an additional 3,752 shares during the last quarter. 76.47% of the stock is owned by institutional investors.

Top Allstate Stories

Here are a few of the latest stories about ALL:

  • Positive Sentiment: Mizuho raised its price target to $311 from $295 and reiterated an “outperform” rating, implying 16.5% upside from the cited $266.99 share price. Mizuho ratings
  • Positive Sentiment: Zacks Research lifted estimates for several periods, including fiscal 2026 EPS to $37.28 from $33.83 and fiscal 2028 EPS to $26.52 from $24.42. These upward revisions offer a positive earnings signal, although Zacks maintains a “hold” rating. Allstate analyst coverage
  • Neutral Sentiment: Other Zacks revisions were mixed: some 2027 quarterly forecasts were raised, while estimates for Q1 2028 and Q3 2027 were lowered. A separate report cited an average analyst price target of $273.48, suggesting more limited upside than Mizuho’s target. Average analyst price target report

About Allstate

(Get Free Report)

Allstate Corporation is a U.S.-based insurance company that provides property and casualty coverage and related protection products. Its offerings include auto, homeowners, renters, condominium, motorcycle and recreational vehicle insurance, as well as life insurance and roadside assistance. The company sells products through its Allstate-branded business and other businesses, including National General, using agents and direct-to-consumer channels. Allstate primarily serves customers in the United States.

Further Reading

Analyst Recommendations for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.